Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT07019090 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07019090
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-27
- Primary completion
- 2026-10-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.